Financhill
Buy
58

PB Quote, Financials, Valuation and Earnings

Last price:
$74.88
Seasonality move :
-0.91%
Day range:
$73.59 - $74.82
52-week range:
$61.07 - $80.69
Dividend yield:
3.14%
P/E ratio:
13.03x
P/S ratio:
4.07x
P/B ratio:
0.95x
Volume:
1.7M
Avg. volume:
1.2M
1-year change:
-7.66%
Market cap:
$7.3B
Revenue:
$1.7B
EPS (TTM):
$5.72

PB Analysts' Consensus Rating

The 12 analysts providing 12-month price projections for Prosperity Bancshares, Inc. shares anticipate an average target of $78.00, ranging from a low estimate of $68.00 to a high estimate of $85.00. This average target implies a growth of 4.68% compared to the current stock price of $74.51.

Consensus Price Target

$78.00

Highest Price Target

$85.00

Lowest Price Target

$68.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 5 5 4

Hold 5 7 8

Sell 0 0 0
Consensus Leans Bullish Hold Hold

PB Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
53
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 30x

Alerts

Sell
40
BILL alert for Feb 9

Bill Holdings, Inc. [BILL] is up 3.7% over the past day.

Buy
75
PRLB alert for Feb 9

Proto Labs, Inc. [PRLB] is down 2.16% over the past day.

Sell
30
MSTR alert for Feb 9

Strategy, Inc. [MSTR] is up 2.59% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock